Barclays
VTVT icon

Barclays’s vTv Therapeutics VTVT Stock Holding History

Barclays’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43K Buy
+36
New +$1.31K ﹤0.01% 4882
2021
Q4 		– Sell
-38
Closed -$2K – 4778
2021
Q3 		$2K Sell
38
-43
-53% -$3.24K ﹤0.01% 4679
2021
Q2 		$7K Sell
81
-167
-67% -$16.9K ﹤0.01% 4718
2021
Q1 		$28K Buy
248
+159
+179% +$15.6K ﹤0.01% 4311
2020
Q4 		$7K Sell
89
-27
-23% -$2.07K ﹤0.01% 4774
2020
Q3 		$9K Sell
116
-15
-11% -$1.32K ﹤0.01% 5029
2020
Q2 		$12K Buy
131
+90
+220% +$8.89K ﹤0.01% 5302
2020
Q1 		$3K Sell
41
-3,148
-99% -$303K ﹤0.01% 5998
2019
Q4 		$217K Buy
+3,189
New +$194K ﹤0.01% 4975
2019
Q3 		– Sell
-116
Closed -$7K – 7165
2019
Q2 		$7K Sell
116
-584
-83% -$35.1K ﹤0.01% 6638
2019
Q1 		$48K Hold
700
– – ﹤0.01% 5910
2018
Q4 		$74K Buy
700
+550
+367% +$50.9K ﹤0.01% 5246
2018
Q3 		$5K Sell
150
-223
-60% -$10.5K ﹤0.01% 6799
2018
Q2 		$23K Buy
373
+321
+617% +$23.7K ﹤0.01% 6111
2018
Q1 		$8K Hold
52
– – ﹤0.01% 6712
2017
Q4 		$13K Buy
52
+40
+333% +$8.97K ﹤0.01% 6459
2017
Q3 		$3K Sell
12
-11
-48% -$2.19K ﹤0.01% 6612
2017
Q2 		$5K Buy
23
+19
+475% +$3.96K ﹤0.01% 6252
2017
Q1 		$1K Sell
4
-8
-67% -$1.82K ﹤0.01% 6642
2016
Q4 		$2K Buy
12
+11
+1,100% +$2.53K ﹤0.01% 6380
2016
Q3 		$0 Buy
+1
New +$241 ﹤0.01% 6816

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Barclays's VTVT Position: Q1 2026 in Review

Barclays opened a new position in vTv Therapeutics (VTVT) in Q1 2026: 36 shares worth $1.43K. The stake represents ﹤0.01% of the portfolio and ranks #4882 among its holdings. This is a return to the name: Barclays previously reported a position in VTVT as recently as Q3 2021.

Barclays first reported a position in VTVT in Q3 2016 and has held it in 21 quarters since. The position peaked at $217K in Q4 2019. 35 funds tracked by Wall St. Rank hold VTVT as of Q1 2026.

  • Barclays held 36 shares of vTv Therapeutics worth $1.43K as of Q1 2026.
  • vTv Therapeutics was a new Barclays position in Q1 2026.
  • vTv Therapeutics made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4882 holding.
  • Barclays first reported a position in vTv Therapeutics in Q3 2016 and has held it in 21 quarters since.
  • Barclays's vTv Therapeutics position peaked at $217K in Q4 2019.
  • 35 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.